| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University, Nashville, TN 37232
Autoantibodies to insulin arise spontaneously in the insulin autoimmune syndrome and in type I diabetes. In addition, administration of insulin to individuals without autoimmune disease routinely results in Abs that bind autologous hormone. These observations and findings in transgenic models of tolerance led to an inference that physiological levels of hormones and growth factors, such as insulin, are not sufficient to induce tolerance in B cells, a state termed clonal ignorance. In contrast, we have discovered that virtually all conventional B cells expressing a low affinity anti-insulin transgene interact with endogenous insulin and are effectively silenced for Ig production and for T cell-dependent immune responses. A fraction of transgenic B cells escapes silencing and functions autonomously to produce insulin Abs that may lower fasting blood sugars similar to an insulin autoimmune syndrome. These B cells have characteristics of a B1-like subset and are depleted by hypotonic peritoneal lysis. These findings question the concept of clonal ignorance and show that physiological concentrations of Ag may effectively silence conventional B cells even when the affinity for autoantigen is low. Self-reactivity may arise in the repertoire because of compartmental differences that govern the fate of B cells and not as a result of true clonal ignorance.
This article has been cited by other articles:
|
|
 |
|
  R. A. Henry, C. A. Acevedo-Suarez, and J. W. Thomas Functional Silencing Is Initiated and Maintained in Immature Anti-Insulin B Cells J. Immunol., March 15, 2009; 182(6): 3432 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Duty, P. Szodoray, N.-Y. Zheng, K. A. Koelsch, Q. Zhang, M. Swiatkowski, M. Mathias, L. Garman, C. Helms, B. Nakken, et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors J. Exp. Med., January 16, 2009; 206(1): 139 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Silveira, H. D. Chapman, J. Stolp, E. Johnson, S. L. Cox, K. Hunter, L. S. Wicker, and D. V. Serreze Genes within the Idd5 and Idd9/11 Diabetes Susceptibility Loci Affect the Pathogenic Activity of B Cells in Nonobese Diabetic Mice J. Immunol., November 15, 2006; 177(10): 7033 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Acevedo-Suarez, D. M. Kilkenny, M. B. Reich, and J. W. Thomas Impaired Intracellular Calcium Mobilization and NFATc1 Availability in Tolerant Anti-Insulin B Cells J. Immunol., August 15, 2006; 177(4): 2234 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mandik-Nayak, J. Racz, B. P. Sleckman, and P. M. Allen Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help J. Exp. Med., August 7, 2006; 203(8): 1985 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huang, J. F. Kearney, M. J. Grusby, C. Benoist, and D. Mathis Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen PNAS, March 7, 2006; 103(10): 3734 - 3739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Woodward and J. W. Thomas Multiple Germline {kappa} Light Chains Generate Anti-Insulin B Cells in Nonobese Diabetic Mice J. Immunol., July 15, 2005; 175(2): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Acevedo-Suarez, C. Hulbert, E. J. Woodward, and J. W. Thomas Uncoupling of Anergy from Developmental Arrest in Anti-Insulin B Cells Supports the Development of Autoimmune Diabetes J. Immunol., January 15, 2005; 174(2): 827 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Aplin, C. L. Keech, A. L. de Kauwe, T. P. Gordon, D. Cavill, and J. McCluskey Tolerance through Indifference: Autoreactive B Cells to the Nuclear Antigen La Show No Evidence of Tolerance in a Transgenic Model J. Immunol., December 1, 2003; 171(11): 5890 - 5900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schellekens Immunogenicity of therapeutic proteins Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1257 - 1259. [Full Text] [PDF]
|
|
|
|
|
|
S. Julien, P. Soulas, J.-C. Garaud, T. Martin, and J.-L. Pasquali B Cell Positive Selection by Soluble Self-Antigen J. Immunol., October 15, 2002; 169(8): 4198 - 4204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hulbert, B. Riseili, M. Rojas, and J. W. Thomas Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice J. Immunol., November 15, 2001; 167(10): 5535 - 5538. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
